Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Minerva Pediatrica
|
December 1, 1991
[Nuclear magnetic resonance and iron overload in thalassemia]
F Schettini, D De Mattia, L Cavallo, et al.
Cancer Treatment Reviews
|
October 20, 2024
Corrigendum to "Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications" [Cancer Treat. Rev. 130 (2024) 102816]
F Schettini, F Gattazzo, S Nucera, et al.
ESMO Open
|
July 6, 2023
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis
C Molinelli, F Jacobs, E Agostinetto, et al.
Beneficial Microbes
|
September 23, 2025
A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of irritable bowel syndrome in adults
L Drago, V D Corleto, G Ciprandi, et al.
Waste Management (New York, N.Y.)
|
April 26, 2020
Marine debris on a tropical coastline: Abundance, predominant sources and fate in a region with multiple activities (Fortaleza, Ceará, northeastern Brazil)
Rivelino M Cavalcante, Lidriana S Pinheiro, Carlos E P Teixeira, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia
|
February 19, 2008
From a water resource to a point pollution source: the daily journey of a coastal urban stream
L R Rörig, J G Tundisi, C A F Schettini, et al.
ESMO Open
|
April 19, 2023
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis
F Schettini, O Martínez-Sáez, C Falato, et al.
ESMO Open
|
October 17, 2025
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy
R Gómez-Bravo, B Walbaum, M Bergamino, et al.
ESMO Open
|
April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
F Schettini, B Conte, G Buono, et al.
ESMO Open
|
January 6, 2026
Erratum to "Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study": [ESMO Open 9 (2024) 103989]
F Schettini, F Brasó-Maristany, T Pascual, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Minerva Pediatrica
|
December 1, 1991
[Nuclear magnetic resonance and iron overload in thalassemia]
F Schettini, D De Mattia, L Cavallo, et al.
Cancer Treatment Reviews
|
October 20, 2024
Corrigendum to "Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications" [Cancer Treat. Rev. 130 (2024) 102816]
F Schettini, F Gattazzo, S Nucera, et al.
ESMO Open
|
July 6, 2023
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis
C Molinelli, F Jacobs, E Agostinetto, et al.
Beneficial Microbes
|
September 23, 2025
A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of irritable bowel syndrome in adults
L Drago, V D Corleto, G Ciprandi, et al.
Waste Management (New York, N.Y.)
|
April 26, 2020
Marine debris on a tropical coastline: Abundance, predominant sources and fate in a region with multiple activities (Fortaleza, Ceará, northeastern Brazil)
Rivelino M Cavalcante, Lidriana S Pinheiro, Carlos E P Teixeira, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia
|
February 19, 2008
From a water resource to a point pollution source: the daily journey of a coastal urban stream
L R Rörig, J G Tundisi, C A F Schettini, et al.
ESMO Open
|
April 19, 2023
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis
F Schettini, O Martínez-Sáez, C Falato, et al.
ESMO Open
|
October 17, 2025
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy
R Gómez-Bravo, B Walbaum, M Bergamino, et al.
ESMO Open
|
April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
F Schettini, B Conte, G Buono, et al.
ESMO Open
|
January 6, 2026
Erratum to "Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study": [ESMO Open 9 (2024) 103989]
F Schettini, F Brasó-Maristany, T Pascual, et al.
Page
of 12